BDSX

Biodesix (BDSX)

Biodesix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BDSX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/28	19 : 00	Business Wire	Biodesix to Participate in Two Investor Conferences in June	NASDAQ:BDSX	Biodesix Inc
2024/05/25	05 : 11	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/24	08 : 09	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BDSX	Biodesix Inc
2024/05/21	19 : 00	Business Wire	Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting	NASDAQ:BDSX	Biodesix Inc
2024/05/11	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/11	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/11	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/11	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/11	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/10	05 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/10	05 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/10	05 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/10	05 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BDSX	Biodesix Inc
2024/05/09	05 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BDSX	Biodesix Inc
2024/05/09	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BDSX	Biodesix Inc
2024/05/09	05 : 01	Business Wire	Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management	NASDAQ:BDSX	Biodesix Inc
2024/05/07	19 : 00	Business Wire	Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference	NASDAQ:BDSX	Biodesix Inc
2024/04/24	19 : 00	Business Wire	Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:BDSX	Biodesix Inc
2024/04/10	06 : 00	Business Wire	Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting	NASDAQ:BDSX	Biodesix Inc
2024/04/05	20 : 17	Business Wire	Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement	NASDAQ:BDSX	Biodesix Inc
2024/03/25	19 : 00	Business Wire	Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center	NASDAQ:BDSX	Biodesix Inc
2024/03/01	20 : 11	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BDSX	Biodesix Inc